458 related articles for article (PubMed ID: 29971593)
21. Current place of vasopressin analogues in the treatment of septic shock.
Ertmer C; Rehberg S; Morelli A; Westphal M
Curr Infect Dis Rep; 2008 Sep; 10(5):362-7. PubMed ID: 18687199
[TBL] [Abstract][Full Text] [Related]
22. Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).
Gordon AC; Mason AJ; Perkins GD; Ashby D; Brett SJ
BMJ Open; 2014 Jul; 4(7):e005866. PubMed ID: 24993769
[TBL] [Abstract][Full Text] [Related]
23. Terlipressin or norepinephrine in hyperdynamic septic shock: a prospective, randomized study.
Albanèse J; Leone M; Delmas A; Martin C
Crit Care Med; 2005 Sep; 33(9):1897-902. PubMed ID: 16148457
[TBL] [Abstract][Full Text] [Related]
24. TERLIPRESSIN COMBINED WITH NOREPINEPHRINE IN THE TREATMENT OF SEPTIC SHOCK: A SYSTEMATIC REVIEW.
Mao F; Liang D; Tang Z; Xu Y; Lin L
Shock; 2023 Oct; 60(4):479-486. PubMed ID: 37548701
[TBL] [Abstract][Full Text] [Related]
25. Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
Morelli A; Donati A; Ertmer C; Rehberg S; Kampmeier T; Orecchioni A; Di Russo A; D'Egidio A; Landoni G; Lombrano MR; Botticelli L; Valentini A; Zangrillo A; Pietropaoli P; Westphal M
Crit Care; 2011; 15(5):R217. PubMed ID: 21929764
[TBL] [Abstract][Full Text] [Related]
26. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial.
Lauzier F; Lévy B; Lamarre P; Lesur O
Intensive Care Med; 2006 Nov; 32(11):1782-9. PubMed ID: 17019548
[TBL] [Abstract][Full Text] [Related]
27. Short-term effects of terlipressin bolus infusion on sublingual microcirculatory blood flow during septic shock.
Morelli A; Donati A; Ertmer C; Rehberg S; Orecchioni A; Di Russo A; Pelaia P; Pietropaoli P; Westphal M
Intensive Care Med; 2011 Jun; 37(6):963-9. PubMed ID: 21336777
[TBL] [Abstract][Full Text] [Related]
28. Effect of early vasopressin combined with norepinephrine on short-term mortality in septic shock: A retrospective study based on the MIMIC-IV database.
He D; Zhang L; Hu H; Gu WJ; Lu X; Qiu M; Li C; Yin H; Lyu J
Am J Emerg Med; 2023 Jul; 69():188-194. PubMed ID: 37167890
[TBL] [Abstract][Full Text] [Related]
29. Terlipressin bolus induces systemic vasoconstriction in septic shock.
Peters MJ; Booth RA; Petros AJ
Pediatr Crit Care Med; 2004 Mar; 5(2):112-5. PubMed ID: 14987338
[TBL] [Abstract][Full Text] [Related]
30. A randomized trial comparing terlipressin and noradrenaline in patients with cirrhosis and septic shock.
Choudhury A; Kedarisetty CK; Vashishtha C; Saini D; Kumar S; Maiwall R; Sharma MK; Bhadoria AS; Kumar G; Joshi YK; Sarin SK
Liver Int; 2017 Apr; 37(4):552-561. PubMed ID: 27633962
[TBL] [Abstract][Full Text] [Related]
31. Terlipressin in catecholamine-resistant septic shock patients.
Leone M; Albanèse J; Delmas A; Chaabane W; Garnier F; Martin C
Shock; 2004 Oct; 22(4):314-9. PubMed ID: 15377885
[TBL] [Abstract][Full Text] [Related]
32. [Vasodilatory septic shock refractory to catecholamines: is there a role for terlipressin?].
Fellahi JL; Bénard P; Daccache G; Mourgeon E; Gérard JL
Ann Fr Anesth Reanim; 2003 Jul; 22(7):631-4. PubMed ID: 12946495
[TBL] [Abstract][Full Text] [Related]
33. Timing of vasopressin initiation and mortality in patients with septic shock: analysis of the MIMIC-III and MIMIC-IV databases.
Xu J; Cai H; Zheng X
BMC Infect Dis; 2023 Apr; 23(1):199. PubMed ID: 37013474
[TBL] [Abstract][Full Text] [Related]
34. Comparison of first-line and second-line terlipressin versus sole norepinephrine in fulminant ovine septic shock.
Kampmeier TG; Arnemann PH; Hessler M; Seidel LM; Becker K; Morelli A; Rehberg SW; Ertmer C
Sci Rep; 2018 May; 8(1):7105. PubMed ID: 29740065
[TBL] [Abstract][Full Text] [Related]
35. The Septic Shock 3.0 Definition and Trials: A Vasopressin and Septic Shock Trial Experience.
Russell JA; Lee T; Singer J; Boyd JH; Walley KR;
Crit Care Med; 2017 Jun; 45(6):940-948. PubMed ID: 28333757
[TBL] [Abstract][Full Text] [Related]
36. Hyperoxia and hypertonic saline in patients with septic shock (HYPERS2S): a two-by-two factorial, multicentre, randomised, clinical trial.
Asfar P; Schortgen F; Boisramé-Helms J; Charpentier J; Guérot E; Megarbane B; Grimaldi D; Grelon F; Anguel N; Lasocki S; Henry-Lagarrigue M; Gonzalez F; Legay F; Guitton C; Schenck M; Doise JM; Devaquet J; Van Der Linden T; Chatellier D; Rigaud JP; Dellamonica J; Tamion F; Meziani F; Mercat A; Dreyfuss D; Seegers V; Radermacher P; ;
Lancet Respir Med; 2017 Mar; 5(3):180-190. PubMed ID: 28219612
[TBL] [Abstract][Full Text] [Related]
37. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
38. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
39. Cardiac ischemia in patients with septic shock randomized to vasopressin or norepinephrine.
Mehta S; Granton J; Gordon AC; Cook DJ; Lapinsky S; Newton G; Bandayrel K; Little A; Siau C; Ayers D; Singer J; Lee TC; Walley KR; Storms M; Cooper DJ; Holmes CL; Hebert P; Presneill J; Russell JA;
Crit Care; 2013 Jun; 17(3):R117. PubMed ID: 23786655
[TBL] [Abstract][Full Text] [Related]
40. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
